[Retracted] The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma
- DOI
- 10.1155/2022/7967722
- Published
- 2022-01
- Container
- Oxidative Medicine and Cellular Longevity
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- serious concernRetraction Watch retraction: 1 retraction notice matched this DOI.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1155/2022/7967722,
title = {[Retracted] The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma},
author = {Zengliang Wang and Yirizhati Aili and Yongxin Wang and Nuersimanguli Maimaitiming and Hu Qin and Wenyu Ji and Guofeng Fan and Bo Li},
year = {2022},
journal = {Oxidative Medicine and Cellular Longevity},
doi = {10.1155/2022/7967722},
url = {https://doi.org/10.1155/2022/7967722}
}RIS
TY - JOUR TI - [Retracted] The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma AU - Zengliang Wang AU - Yirizhati Aili AU - Yongxin Wang AU - Nuersimanguli Maimaitiming AU - Hu Qin AU - Wenyu Ji AU - Guofeng Fan AU - Bo Li PY - 2022 JO - Oxidative Medicine and Cellular Longevity DO - 10.1155/2022/7967722 UR - https://doi.org/10.1155/2022/7967722 ER -
APA
Wang, Z., Aili, Y., Wang, Y., Maimaitiming, N., Qin, H., Ji, W., Fan, G., & Li, B. (2022). [Retracted] The RPL4P4 Pseudogene Is a Prognostic Biomarker and Is Associated with Immune Infiltration in Glioma. Oxidative Medicine and Cellular Longevity. https://doi.org/10.1155/2022/7967722
Source records
- crossref · retrieved 2026-09-25T00:39:25.886Z